Edition:
India

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

68.20USD
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
$68.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
705,814
52-wk High
$69.63
52-wk Low
$45.48

Select another date:

Mon, Jan 8 2018

BRIEF-Baxter International-‍​On Jan 1,Administrative Committee Of Compensation Committee Of Board Approved Amendment To Reorganize Co's, Units Pension Plan

* BAXTER INTERNATIONAL-‍​ON JAN 1,ADMINISTRATIVE COMMITTEE OF COMPENSATION COMMITTEE OF BOARD APPROVED AMENDMENT TO REORGANIZE CO'S,UNITS PENSION PLAN

BRIEF-Baxter To Acquire Recothrom, Preveleak For Upfront Payment Of About $153 Mln

* BAXTER ANNOUNCES AGREEMENT TO BROADEN PORTFOLIO OF INNOVATIVE SURGICAL PRODUCTS

Baxter expects $70 million hit to fourth-quarter sales from Hurricane Maria

U.S. hospital products maker Baxter International Inc on Wednesday forecast a nearly $70 million hit to its fourth-quarter revenue, due to manufacturing disruptions arising from Hurricane Maria.

UPDATE 2-Baxter expects $70 mln hit to 4th-qtr sales from Hurricane Maria

* Shares slightly lower (Adds share price, CEO comments from analyst call)

Baxter expects $70 mln hit to 4th-qtr sales from Hurricane Maria

Oct 25 Hospital products maker Baxter International Inc on Wednesday forecast a nearly $70 million hit to its fourth-quarter revenue due to manufacturing disruptions arising from Hurricane Maria.

BRIEF-Baxter provides update on Puerto Rico recovery status post Hurricane Maria

* Baxter provides update on Puerto Rico recovery status post Hurricane Maria

BRIEF-Baxter International Inc - ‍launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System​

* Baxter International Inc - ‍launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Baxter International ‍announces commercial launch of new indication for oXiris set​

* Baxter launches first 3-in-1 set for use in continuous renal replacement therapy and sepsis management protocols

BRIEF-Baxter and MATTER Healthcare on patient-driven innovation

* Baxter and MATTER Healthcare Incubator Partner on patient-driven innovation

Big-name U.S. hedge funds shed healthcare stocks during the rally in second quarter

NEW YORK Several big-name hedge fund investors trimmed their stakes in healthcare companies in the second quarter as the sector led the broad U.S. stock market higher, rallying amid a Republican effort to repeal and replace President Obama's signature healthcare law.

Select another date: